In addition, reversal of insulin resistance in ob/ob mice with rosiglitazone, a peroxisome proliferator-activated receptor (PPAR) γ agonist, leads to decreased CD36 expression on PerMΦs [7]. This evidence concerns the gene CD36 and Insulin resistance.